Care Atlas

CMS Open Payments · 2024

Dr. Ronald Lehman

Orthopaedic Surgery · NEW YORK, NY · NPI 1528007358

Many doctors share a name — check the specialty and city above match your doctor before you read this as theirs.

$632,952 reported by drug & device companies in 2024 · 145 payments

Not all payments mean the same thing. Split apart:

$150,179
Promotional

Meals, speaking fees, travel, consulting — money from companies marketing their products. This is the relationship to weigh against a recommendation. For this doctor it is substantial.

$482,774
Royalty / ownership

Income for a device or method the doctor invented or owns — large for some surgeons, and not a conflict over what to prescribe you.

This is well above what most doctors receive in promotional payments — a relationship worth being aware of when weighing a recommendation.

Largest paying companies

The companies that paid this doctor the most in 2024 — each company's full total (promotional + research + royalty), from CMS's separate by-company report, so these may not add up to the split above.

Medtronic, Inc. $564,138
Stryker Corporation $58,535
Ethicon US, LLC $9,431
Synthes GmbH $500
Medical Device Business Services, Inc. $150

What the payments were for

Royalty or license $482,274Consulting fees $83,871Speaking / services (non-CE) $51,525Travel & lodging $10,259Food & beverage $4,523Long-term device/supply loan $500

What this is — and is not

This is the public record companies are required by law to report (the Sunshine Act). A disclosed payment is a financial relationship — it is not proof of wrongdoing, and not evidence that it changed your care. Many payments are entirely legitimate (research, royalties for inventions, education). The point is transparency: you get to know, and to ask. It is not a rating of Dr. Ronald Lehman.

Also available: structured data · plain text. Verify at CMS Open Payments (NPI 1528007358).